Status:
AVAILABLE
A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate Cancer
Lead Sponsor:
Matrix Biomed, Inc.
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Brief Summary
A single patient compassionate use clinical trial for the use of MBM-02 (TEMPOL) for the treatment of prostate cancer. The single patient will be exposed to orally administered TEMPOL for up to 12 mon...
Detailed Description
Localized therapy for prostate cancer is often curative; however, 20% to 30% of patients experience a recurrence. Biochemical recurrence (BCR) occurs in an estimated 50,000 men/year in the U.S and is ...
Eligibility Criteria
Inclusion
- Biochemical Recurrent Prostate Cancer
Exclusion
- \-
Key Trial Info
Start Date :
Trial Type :
EXPANDED_ACCESS
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04337099
Last Update
May 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prostate Oncology Specialists
Marina del Rey, California, United States, 90292